Nutriband Inc (NTRB) Peer Comparison
$7.35
$0.59
(8.73%)
As on 23-Sep-2026 15:30EDT
Market cap
$99 Mln
Revenue (TTM)
$2 Mln
P/E Ratio
--
P/B Ratio
18.5
Div. Yield
0 %
Edit
| Nutriband Inc (NTRB) | Heart Test Laboratories Inc. (HSCS) | Medtronic PLC (MDT) | Veeva Systems Inc. Class A (VEEV) | Agilent Technologies (A) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
99 | 25 | 118,666 | 42,703 | 44,113 |
Revenue ($ Mln) |
2 | 90 | 37,542 | 3,458 | 7,372 |
Net Profit ($ Mln) |
-6.96 | -10.26 | 5,230.00 | 1,014.77 | 1,440.00 |
Net Margin (%) |
-430.43 | -11.46 | 13.93 | 29.34 | 19.53 |
RoE (%) |
-115.97 | -- | 10.47 | 13.86 | 20.18 |
Price to Earnings |
-- | -- | 22.85 | 43.45 | 30.86 |
Price-To-Book |
18.49 | 70.85 | 2.36 | 5.77 | 5.99 |
Income Statement ($ Mln)
| Nutriband Inc (NTRB) | Heart Test Laboratories Inc. (HSCS) | Medtronic PLC (MDT) | Veeva Systems Inc. Class A (VEEV) | Agilent Technologies (A) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
2.04 | 0.00 | 36,364.00 | 3,195.31 | 6,948.00 |
|
Cost of Revenue
|
1.47 | 0.13 | 12,721.00 | 782.02 | 3,305.00 |
|
Gross Profit
|
0.57 | -0.13 | 23,643.00 | 2,413.29 | 3,643.00 |
|
Operating Expenses
|
8.88 | 8.28 | 17,179.00 | 1,496.92 | 2,164.00 |
|
Operating Profit (EBIT)
|
-8.32 | -8.41 | 6,467.00 | 916.37 | 1,479.00 |
|
Other Income
|
-- | -- | -- | -- | -- |
|
Profit before Tax
|
-8.23 | -9.14 | 6,136.00 | 1,194.51 | 1,435.00 |
|
Provision for Tax
|
-- | -3.68 | 1,299.00 | 285.60 | 132.00 |
|
Profit after Tax (Net Income)
|
-8.23 | -9.14 | 4,800.00 | 908.91 | 1,303.00 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Consolidated Profit
|
-- | -- | 4,662.00 | -- | 1,303.00 |
Liabilities ($ Mln)
| Nutriband Inc (NTRB) | Heart Test Laboratories Inc. (HSCS) | Medtronic PLC (MDT) | Veeva Systems Inc. Class A (VEEV) | Agilent Technologies (A) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
6.68 | 225.53 | 49,463.00 | 7,214.75 | 6,741.00 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Non-Current Liabilities
|
0.08 | 175.50 | 31,298.00 | 127.54 | 3,639.00 |
|
Current Liabilities
|
0.78 | 4,861.11 | 11,658.00 | 1,637.06 | 2,347.00 |
|
Total Liabilities
|
7.55 | 5,262.67 | 93,028.00 | 8,979.34 | 12,727.00 |
Assets ($ Mln)
| Nutriband Inc (NTRB) | Heart Test Laboratories Inc. (HSCS) | Medtronic PLC (MDT) | Veeva Systems Inc. Class A (VEEV) | Agilent Technologies (A) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
2.56 | 2,679.75 | 68,240.00 | 981.71 | 8,133.00 |
|
Current Assets
|
4.99 | 2,582.93 | 24,787.00 | 7,997.63 | 4,594.00 |
|
Total Assets
|
7.55 | 5,262.14 | 93,028.00 | 8,979.34 | 12,727.00 |
|
Total Debt*
|
0.25 | 3,936.65 | 27,961.00 | 95.86 | 3,354.00 |
|
Net Current Assets
|
4.20 | -2.28 | 13,129.00 | 6,360.57 | 2,247.00 |
Cashflow ($ Mln)
| Nutriband Inc (NTRB) | Heart Test Laboratories Inc. (HSCS) | Medtronic PLC (MDT) | Veeva Systems Inc. Class A (VEEV) | Agilent Technologies (A) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-5.13 | -7.43 | 7,330.00 | 1,415.23 | 1,559.00 |
|
Cash Flow from Investing Activities
|
-0.01 | -0.04 | -2,934.00 | -1,104.36 | -394.00 |
|
Cash from Financing Activities
|
5.40 | 8.03 | -4,751.00 | -9.33 | -715.00 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Nutriband Inc (NTRB) | Heart Test Laboratories Inc. (HSCS) | Medtronic PLC (MDT) | Veeva Systems Inc. Class A (VEEV) | Agilent Technologies (A) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-121.56 | -0.44 | 6.24 | 13.75 | 13.32 |
|
ROE (%)
|
-125.56 | -8.10 | 9.85 | 13.93 | 20.62 |
|
ROA (%)
|
-109.60 | -0.35 | 5.20 | 11.14 | 10.61 |
|
EBIT Margin (%)
|
-- | -- | -- | -- | -- |
|
Net Margin (%)
|
-404.08 | -211,666.47 | 13.20 | 28.44 | 18.75 |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| Nutriband Inc (NTRB) | Heart Test Laboratories Inc. (HSCS) | Medtronic PLC (MDT) | Veeva Systems Inc. Class A (VEEV) | Agilent Technologies (A) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-0.05 | -0.01 | 0.08 | 0.16 | 0.07 |
|
EBIT Growth (%)
|
-- | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
21.50 | -4.30 | 2.96 | 27.27 | 1.09 |
|
EPS Growth (%)
|
-- | -- | -- | -- | -- |
|
Book Value Growth (%)
|
-- | -- | -- | -- | -- |
Valuation Ratios
| Nutriband Inc (NTRB) | Heart Test Laboratories Inc. (HSCS) | Medtronic PLC (MDT) | Veeva Systems Inc. Class A (VEEV) | Agilent Technologies (A) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-- | -- | -- | -- | -- |
|
Price / Book Value
|
-- | -- | -- | -- | -- |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
0.54 | -270.99 | 1.91 | -5.19 | 0.85 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Nutriband Inc (NTRB) | Heart Test Laboratories Inc. (HSCS) | Medtronic PLC (MDT) | Veeva Systems Inc. Class A (VEEV) | Agilent Technologies (A) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.04 | 17.46 | 0.57 | 0.01 | 0.50 |
|
Short term debt to equity ratio
|
0.02 | 16.68 | 0.04 | 0.00 | 0.05 |
|
Current Ratio
|
6.36 | 0.53 | 2.13 | 4.89 | 1.96 |
|
Quick Ratio
|
6.21 | 0.40 | 1.62 | -- | 1.52 |
|
Interest Coverage
|
-364.19 | -21.72 | 9.58 | -- | 13.81 |
Operating Efficiency Ratios
| Nutriband Inc (NTRB) | Heart Test Laboratories Inc. (HSCS) | Medtronic PLC (MDT) | Veeva Systems Inc. Class A (VEEV) | Agilent Technologies (A) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
5.81 | 0.00 | 18.27 | 41.01 | 21.40 |
|
Asset Turnover
|
0.27 | 0.00 | 0.39 | 0.39 | 0.57 |
|
Receivable days
|
17.24 | 183.94 | 66.08 | 135.31 | 73.89 |
|
Inventory Days
|
40.99 | 900,351.58 | 164.05 | -- | 111.40 |
|
Payable days
|
149.23 | 437,150.98 | 73.12 | 15.90 | 61.34 |
|
Cash Conversion Cycle
|
-91.00 | 463,384.53 | 157.01 | -- | 123.95 |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
